Braskem (BRKM5) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
9 Jul, 2026Executive summary
Recurring EBITDA reached US$150 million in 3Q25, up 104% sequentially but down 65% year-over-year, driven by higher value-added sales and resilience initiatives amid a prolonged industry downturn.
Net loss attributable to shareholders was US$1 million, mainly due to provisions for the Alagoas geological event and plant hibernation, a significant improvement from prior quarters.
Cash position at quarter-end was US$1.3 billion, with total liquidity of US$2.3 billion including a US$1 billion stand-by credit line drawn in October.
The company advanced its Resilience and Transformation Program, focusing on cost reduction, asset optimization, regulatory actions, and approval of the Transforma Rio project.
Major legal settlement in Alagoas for R$1.2 billion, resolving significant exposure and enabling progress on environmental and urban remediation.
Financial highlights
Net revenue was US$3.18 billion for 3Q25, up 1% sequentially but down 17% year-over-year; consolidated recurring EBITDA was US$150 million, up 104% sequentially but down 65% year-over-year.
Operating cash consumption was US$61 million (R$334 million), mainly due to CAPEX, maintenance, and debt interest payments.
EBITDA margin improved to 11.3% in 3Q25 from 4.7% in 2Q25, but was down from 11% in 3Q24.
Adjusted net debt/recurring EBITDA rose to 14.76x at quarter-end, reflecting lower trailing 12-month EBITDA.
Net loss attributable to shareholders was R$174 million for the quarter, a significant improvement from R$869 million in 3Q2024.
Outlook and guidance
The industry environment is expected to remain structurally challenging until at least 2030, with recovery projected after 2029.
Strategic priorities include advancing asset transformation, implementing contingency initiatives, and promoting competitiveness in the Brazilian chemical industry.
Regulatory and market protection measures, such as anti-dumping duties and import tax maintenance, are expected to support the sector.
Latest events from Braskem
- EBITDA surged 121% to US$224M, but Alagoas-related risks remain significant.BRKM5
Q1 20259 Jul 2026 - EBITDA surged 39–46%, but net loss widened on currency impacts; liquidity remains strong.BRKM5
Q2 20248 Jul 2026 - Recurring EBITDA fell 49% and net loss reached R$10,961m amid high leverage and industry downturn.BRKM5
Q4 20258 Jul 2026 - EBITDA rose 76% sequentially, but leverage, cash burn, and legal risks remain high.BRKM5
Q1 20267 Jul 2026 - EBITDA plunged 67%, leverage hit 10.59x, and legal, market, and cash flow risks remain.BRKM5
Q2 20257 Jul 2026 - EBITDA up 46% to US$1.1B, but FX losses led to a net loss; strong liquidity and green focus.BRKM5
Q4 20243 Jul 2026 - EBITDA hit a two-year high on margin gains, but legal and currency risks remain.BRKM5
Q3 20243 Jul 2026 - 2030 targets: 1M tons each of bio-based and recycled products, with ambitious decarbonization goals.BRKM5
Investor Day 202412 Jan 2026